Breakthrough medicines for effective treatment of neurological disorders

Program

Indication

Target to Hit

Hit to Lead

Lead Optimisation

IND Enabling

Phase I

2NP01

ALS

2NP02

Huntington's

2NP03

Parkinson's

2NP04

SPMS